Homology modeling of TMPRSS2 yields candidate drugs that may inhibit entry of SARS-CoV-2 into human cells.

The most rapid path to discovering treatment options for the novel coronavirus SARS-CoV-2 is to find existing medications that are active against the virus. We have focused on identifying repurposing candidates for the transmembrane serine protease family member II (TMPRSS2), which is critical for e...

Descripción completa

Detalles Bibliográficos
Autores principales: Rensi, Stefano, Keys, Allison, Lo, Yu-Chen, Derry, Alexander, McInnes, Greg, Liu, Tianyun, Altman, Russ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ChemRxiv 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263764/
https://www.ncbi.nlm.nih.gov/pubmed/32511288
http://dx.doi.org/10.26434/chemrxiv.12009582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263764/
https://www.ncbi.nlm.nih.gov/pubmed/32511288
http://dx.doi.org/10.26434/chemrxiv.12009582

Ejemplares similares